Merideth M Wendland

2.0k total citations · 1 hit paper
27 papers, 1.4k citations indexed

About

Merideth M Wendland is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Merideth M Wendland has authored 27 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Genetics, 19 papers in Pulmonary and Respiratory Medicine and 8 papers in Oncology. Recurrent topics in Merideth M Wendland's work include Glioma Diagnosis and Treatment (21 papers), Brain Metastases and Treatment (17 papers) and Cancer-related cognitive impairment studies (7 papers). Merideth M Wendland is often cited by papers focused on Glioma Diagnosis and Treatment (21 papers), Brain Metastases and Treatment (17 papers) and Cancer-related cognitive impairment studies (7 papers). Merideth M Wendland collaborates with scholars based in United States, Canada and Israel. Merideth M Wendland's co-authors include Minesh P. Mehta, Dennis C. Shrieve, Stephanie L. Pugh, Vijayananda Kundapur, Wolfgang A. Tomé, Lisa A. Kachnic, Glenn Bauman, André Konski, Albert S. DeNittis and Jeffrey Greenspoon and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Merideth M Wendland

26 papers receiving 1.4k citations

Hit Papers

Preservation of Memory With Conformal Avoidance of the Hi... 2014 2026 2018 2022 2014 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Preservation of Memory With Conformal Avoidance of the Hippocampal Neural Stem-Cell Compartment During Whole-Brain Radiotherapy for Brain Metastases (RTOG 0933): A Phase II Multi-Institutional Trial
    2014 768 citations Vinai Gondi, Stephanie L. Pugh et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Merideth M Wendland United States 15 910 825 477 327 157 27 1.4k
Koichi Mitsuya Japan 22 577 0.6× 461 0.6× 650 1.4× 147 0.4× 94 0.6× 84 1.4k
Mario Ammirati United States 17 741 0.8× 702 0.9× 413 0.9× 468 1.4× 217 1.4× 28 1.5k
Valérie Panet-Raymond Canada 16 414 0.5× 474 0.6× 306 0.6× 289 0.9× 158 1.0× 50 1.4k
Patty A. Kormanik United States 19 777 0.9× 707 0.9× 469 1.0× 163 0.5× 251 1.6× 27 1.2k
Émeline Tabouret France 23 604 0.7× 1.0k 1.3× 415 0.9× 282 0.9× 317 2.0× 103 1.8k
Ricardo Yayá Spain 11 655 0.7× 888 1.1× 419 0.9× 156 0.5× 200 1.3× 26 1.5k
Silvia Scoccianti Italy 20 680 0.7× 541 0.7× 356 0.7× 249 0.8× 116 0.7× 75 1.6k
L. Feuvret France 19 563 0.6× 490 0.6× 193 0.4× 234 0.7× 94 0.6× 80 1.1k
Erik Parker United States 15 438 0.5× 635 0.8× 294 0.6× 221 0.7× 170 1.1× 31 1.1k
B. Fisher Canada 11 888 1.0× 1.3k 1.5× 431 0.9× 431 1.3× 384 2.4× 28 2.0k

Countries citing papers authored by Merideth M Wendland

Since Specialization
Citations

This map shows the geographic impact of Merideth M Wendland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Merideth M Wendland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Merideth M Wendland more than expected).

Fields of papers citing papers by Merideth M Wendland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Merideth M Wendland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Merideth M Wendland. The network helps show where Merideth M Wendland may publish in the future.

Co-authorship network of co-authors of Merideth M Wendland

This figure shows the co-authorship network connecting the top 25 collaborators of Merideth M Wendland. A scholar is included among the top collaborators of Merideth M Wendland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Merideth M Wendland. Merideth M Wendland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Scheurer, Michael E., Renke Zhou, Mark R. Gilbert, et al.. (2022). Germline polymorphisms in MGMT associated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825. Neuro-Oncology Advances. 4(1). vdac152–vdac152.
2.
Redmond, Kristin J., Jimm Grimm, Clifford G. Robinson, et al.. (2020). Steep Dose-response Relationship between Maximum Hippocampal Dose and Memory Deficits following Hippocampal Avoidance Whole Brain Radiation Therapy (HA-WBRT) for Brain Metastases: A Secondary Analysis of NRG/RTOG 0933. International Journal of Radiation Oncology*Biology*Physics. 108(3). S176–S176. 1 indexed citations
3.
Laack, Nadia N., Stephanie L. Pugh, Paul D. Brown, et al.. (2018). The association of health-related quality of life and cognitive function in patients receiving memantine for the prevention of cognitive dysfunction during whole-brain radiotherapy. Neuro-Oncology Practice. 6(4). 274–282. 14 indexed citations
4.
Hall, William A., Stephanie L. Pugh, Jeffrey S. Wefel, et al.. (2018). Influence of Residual Disease Following Surgical Resection in Newly Diagnosed Glioblastoma on Clinical, Neurocognitive, and Patient Reported Outcomes. Neurosurgery. 84(1). 66–76. 7 indexed citations
5.
Chinnaiyan, Prakash, Minhee Won, Patrick Y. Wen, et al.. (2017). A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: results of NRG Oncology RTOG 0913. Neuro-Oncology. 20(5). 666–673. 108 indexed citations
6.
Caine, Chip, Snehal Deshmukh, Vinai Gondi, et al.. (2015). CogState computerized memory tests in patients with brain metastases: secondary endpoint results of NRG Oncology RTOG 0933. Journal of Neuro-Oncology. 126(2). 327–336. 30 indexed citations
7.
Gondi, Vinai, Stephanie L. Pugh, Wolfgang A. Tomé, et al.. (2014). Preservation of Memory With Conformal Avoidance of the Hippocampal Neural Stem-Cell Compartment During Whole-Brain Radiotherapy for Brain Metastases (RTOG 0933): A Phase II Multi-Institutional Trial. Journal of Clinical Oncology. 32(34). 3810–3816. 768 indexed citations breakdown →
8.
Chinnaiyan, Prakash, Minhee Won, Patrick Y. Wen, et al.. (2013). RTOG 0913: A phase I study of daily everolimus (RAD001) in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma.. Journal of Clinical Oncology. 31(15_suppl). 2047–2047. 1 indexed citations
9.
Wefel, Jeffrey S., Stephanie L. Pugh, Terri S. Armstrong, et al.. (2013). Neurocognitive function (NCF) outcomes in patients with glioblastoma (GBM) enrolled in RTOG 0825.. Journal of Clinical Oncology. 31(15_suppl). 2004–2004. 14 indexed citations
10.
Chinnaiyan, Prakash, Minhee Won, Patrick Y. Wen, et al.. (2013). RTOG 0913: A Phase 1 Study of Daily Everolimus (RAD001) in Combination With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma. International Journal of Radiation Oncology*Biology*Physics. 86(5). 880–884. 56 indexed citations
11.
Jensen, Randy L., et al.. (2008). NOVALIS INTENSITY-MODULATED RADIOSURGERY. Neurosurgery. 62(5). A2–A10. 10 indexed citations
12.
Ragel, Brian T., William T. Couldwell, David L. Gillespie, et al.. (2008). A comparison of the cell lines used in meningioma research. Surgical Neurology. 70(3). 295–307. 40 indexed citations
13.
Kan, Peter, James K. Liu, Merideth M Wendland, Dennis C. Shrieve, & Randy L. Jensen. (2007). Peritumoral edema after stereotactic radiosurgery for intracranial meningiomas and molecular factors that predict its development. Journal of Neuro-Oncology. 83(1). 33–38. 49 indexed citations
14.
Wendland, Merideth M, Kenneth M. Boucher, Julie Asch, et al.. (2007). The Impact of Involved Field Radiation Therapy in the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma With High-Dose Chemotherapy Followed by Hematopoietic Progenitor Cell Transplant. American Journal of Clinical Oncology. 30(2). 156–162. 16 indexed citations
15.
Tward, Jonathan D., Merideth M Wendland, Dennis C. Shrieve, Anikó Szabó, & David K. Gaffney. (2006). The risk of secondary malignancies over 30 years after the treatment of non‐Hodgkin lymphoma. Cancer. 107(1). 108–115. 147 indexed citations
16.
Wendland, Merideth M, Julie Asch, Michael A. Pulsipher, et al.. (2006). The Impact of Involved Field Radiation Therapy for Patients Receiving High-Dose Chemotherapy Followed by Hematopoietic Progenitor Cell Transplant for the Treatment of Relapsed or Refractory Hodgkin Disease. American Journal of Clinical Oncology. 29(2). 189–195. 27 indexed citations
17.
Wendland, Merideth M, Dennis C. Shrieve, Gordon A. Watson, Steven S. Chin, & Deborah T. Blumenthal. (2006). Extraneural metastatic medulloblastoma in an adult. Journal of Neuro-Oncology. 78(2). 191–196. 7 indexed citations
18.
Wendland, Merideth M, Alexander Tsodikov, Martha Glenn, & David K. Gaffney. (2004). Time interval to the development of breast carcinoma after treatment for Hodgkin disease. Cancer. 101(6). 1275–1282. 9 indexed citations
19.
Shrieve, Dennis C., et al.. (2004). Basic principles of radiobiology, radiotherapy, and radiosurgery. Neurosurgery Clinics of North America. 15(4). 467–479. 16 indexed citations
20.
Wendland, Merideth M & William T. Sause. (2003). Induction chemotherapy followed by radical local therapy for locally advanced non‐small cell lung cancer. Seminars in Surgical Oncology. 21(2). 111–121. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Koichi Mitsuya Breakdown of academic impact, for papers by Mario Ammirati Breakdown of academic impact, for papers by Valérie Panet-Raymond Breakdown of academic impact, for papers by Patty A. Kormanik Breakdown of academic impact, for papers by Émeline Tabouret Breakdown of academic impact, for papers by Ricardo Yayá Breakdown of academic impact, for papers by Silvia Scoccianti Breakdown of academic impact, for papers by L. Feuvret Breakdown of academic impact, for papers by Erik Parker Breakdown of academic impact, for papers by B. Fisher
Rankless by CCL
2026